India and the Patent Wars : Pharmaceuticals in the New Intellectual Property Regime / Murphy Halliburton.

Frontmatter -- Contents -- Acknowledgments -- Note on Names of Medications -- Introduction -- 1. The Invention and Expansion of Intellectual Property -- 2. The New Patent Regime -- 3. Ayurvedic Dilemmas -- 4. The Gilead Model and the Perspective of Big Pharma -- 5. The View from Hyderabad -- Conclusion -- Notes -- References -- Index

restricted access online access with authorization star

http://purl.org/coar/access_right/c_16ec

India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States.India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India's largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.

Mode of access: Internet via World Wide Web.

In English.

Description based on online resource; title from PDF title page (publisher's Web site, viewed 26. Nov 2019)